Traino AC, di Martino F, Lazzeri M, Stabin MG. Influence of thyroid volume reduction on calculated dose in radioiodine therapy of Graves' hyperthyroidism. Phys Med Biol 2000; 45: 121-29.
Becker DV. Choice of therapy for Graves' hyperthyroidism. N Eng J Med 1989; 311: 454-66.
Farrar JJ, Toft AD. Iodine-131 treatment of hyperthyroidism. Clin Endocrinol Oxf 1991; 35: 207-12.
Vardar E, Erkan N, Bayol U, Yılmaz C, Dogan M. Metastatic tumours to the thyroid gland: report of 3 cases and brief review of the literature. Radiol Oncol 2011; 45: 53-8. [Web of Science]
Van Isselt JW, de Klerk JMH, Van Rijk PP, Van Gils APG, Polman LJ, Kamphuis C, Meijer R, Beekman FJ. Comparison of methods for thyroid volume estimation in patients with Graves' disease. Eur J Nucl Med Mol Imaging 2003; 30: 525-31. [Crossref] [PubMed]
Snyder W, Ford M, Warner G. Estimates of absorbed fractions for monoenergetic photon sources uniformly distributed in various organs of a heterogeneous phantom: MIRD pamphlet no. 5. J Nucl Med 1969; 10 (Suppl 3): 5-52.
Waters L S. MCNPX User's Manual, version 2.3.0. Los Alamos; 2002. [Web of Science]
Eckerman KF, Westfall RJ, Ryman JC, Cristy M. Availability of nuclear decay data in electronic form, including beta spectra not previously published. Health Phys 1994; 67: 338-45.
Cember H, Johnson TE. Introduction to health physics. New York: McGraw-Hill; 2009.
Published Online: 2011-03-29
Published in Print: 2011-06-01
Citation Information: Radiology and Oncology. Volume 45, Issue 2, Pages 143–146, ISSN (Online) 1581-3207, ISSN (Print) 1318-2099, DOI: https://doi.org/10.2478/v10019-011-0008-5, March 2011
This content is open access.